Article Versions Notes

Feng Y, Pan X, Li Z, Li Y, Sun Y, Yang S, He C, Dang Y, Huang L, Xiang B. Innovative Lipid Nanoparticles Co-Delivering Hydroxychloroquine and siRNA for Enhanced Rheumatoid Arthritis Therapy. Pharmaceutics. 2025; 17(1):45. https://doi.org/10.3390/pharmaceutics17010045

Feng, Yanru, Xintong Pan, Ziqian Li, Yue Li, Ya’nan Sun, Shaokun Yang, Chaoxing He, Yunjie Dang, Lu Huang, and Bai Xiang. 2025. "Innovative Lipid Nanoparticles Co-Delivering Hydroxychloroquine and siRNA for Enhanced Rheumatoid Arthritis Therapy" Pharmaceutics 17, no. 1: 45. https://doi.org/10.3390/pharmaceutics17010045

Feng, Y., Pan, X., Li, Z., Li, Y., Sun, Y., Yang, S., He, C., Dang, Y., Huang, L., & Xiang, B. (2025). Innovative Lipid Nanoparticles Co-Delivering Hydroxychloroquine and siRNA for Enhanced Rheumatoid Arthritis Therapy. Pharmaceutics, 17(1), 45. https://doi.org/10.3390/pharmaceutics17010045